Once-Monthly GLP-1 Injection Shows Significant Weight Loss Without Plateau in non diabetics in Phase 2 trial

Pfizer reported that its ultra-long-acting, once-monthly GLP-1 injectable achieved up to 12.3% placebo-adjusted weight loss by week 28, with no weight-loss plateau, in adults with obesity or overweight without type…

Continue ReadingOnce-Monthly GLP-1 Injection Shows Significant Weight Loss Without Plateau in non diabetics in Phase 2 trial

USFDA Issues 9 Observations to Aurobindo’s Jedcherla Unit-VII After Inspection

New Delhi: Aurobindo Pharma Limited recently informed that the United States Food and Drug Administration (USFDA) has completed an inspection at its Unit-VII manufacturing facility located at Jedcherla in Telangana.…

Continue ReadingUSFDA Issues 9 Observations to Aurobindo’s Jedcherla Unit-VII After Inspection

OneSource Secures Saudi Nod for Generic Ozempic, Partners Hikma for MENA Rollout

New Delhi: OneSource Specialty Pharma Limited has received regulatory approval in Saudi Arabia to commercialise a generic version of Ozempic (semaglutide), marking a significant milestone for the company's expansion in…

Continue ReadingOneSource Secures Saudi Nod for Generic Ozempic, Partners Hikma for MENA Rollout

Focal Laser Ablation Offers Oncological and Functional Control Compared to Other Focal Therapies: Study

Australia: Researchers have found in a systematic review and meta-analysis that focal laser ablation offers oncological control comparable to other focal therapies while preserving functional outcomes. However, the lack of…

Continue ReadingFocal Laser Ablation Offers Oncological and Functional Control Compared to Other Focal Therapies: Study

Independent Influence of Health Literacy and Diet Predict Uncontrolled Diabetes: Study Finds

A recent cross-sectional study highlights the critical factors, such as lower education levels, high waist-to-hip ratios, and non-vegetarian diets, influencing uncontrolled diabetes mellitus (UDM) among type 2 diabetes mellitus (T2D)…

Continue ReadingIndependent Influence of Health Literacy and Diet Predict Uncontrolled Diabetes: Study Finds

Oral Anticoagulant Discontinuation After AF Ablation: Review Sheds Light on Risks and Benefits

Brazil: Stopping oral anticoagulants (OACs) after atrial fibrillation ablation does not significantly change overall thromboembolic (TE) event rates and is associated with a reduction in major bleeding. However, in patients…

Continue ReadingOral Anticoagulant Discontinuation After AF Ablation: Review Sheds Light on Risks and Benefits